KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Change in Inventory (2016 - 2025)

Amgen has reported Change in Inventory over the past 17 years, most recently at -$119.0 million for Q4 2025.

  • Quarterly results put Change in Inventory at -$119.0 million for Q4 2025, up 63.16% from a year ago — trailing twelve months through Dec 2025 was -$886.0 million (up 65.01% YoY), and the annual figure for FY2025 was -$886.0 million, up 65.01%.
  • Change in Inventory for Q4 2025 was -$119.0 million at Amgen, up from -$240.0 million in the prior quarter.
  • Over the last five years, Change in Inventory for AMGN hit a ceiling of $241.0 million in Q3 2022 and a floor of -$806.0 million in Q1 2024.
  • Median Change in Inventory over the past 5 years was -$40.0 million (2021), compared with a mean of -$150.1 million.
  • Biggest five-year swings in Change in Inventory: skyrocketed 402.08% in 2022 and later crashed 2306.67% in 2024.
  • Amgen's Change in Inventory stood at -$50.0 million in 2021, then skyrocketed by 282.0% to $91.0 million in 2022, then tumbled by 729.67% to -$573.0 million in 2023, then skyrocketed by 43.63% to -$323.0 million in 2024, then surged by 63.16% to -$119.0 million in 2025.
  • The last three reported values for Change in Inventory were -$119.0 million (Q4 2025), -$240.0 million (Q3 2025), and -$239.0 million (Q2 2025) per Business Quant data.